Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Schweiz
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. News
  7. Andere Sprachen
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(A0MSH6)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über ADDEX THERAPEUTICS LTD
12:12ADDEX THERAPEUTICS : CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM..
09:53ADDEX THERAPEUTICS : Charcot-Marie-Tooth Association Team Up to Study Potential of Muscle ..
08:09Addex partenaire de l'association de lutte contre la maladie Charcot Marie Tooth
07:00PRESS RELEASE : CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM as P..
07:00ADDEX THERAPEUTICS : CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM..
07:00CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM as Potential Trea..
08.09.ADDEX THERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment Confe..
08.09.PRESS RELEASE : Addex to Present at the H.C. Wainwright 23rd Annual Global Investment Conf..
02.09.PRESS RELEASE : Addex to Present at the Swiss Biotech Day
02.09.Addex to Present at the Swiss Biotech Day
05.08.ADDEX THERAPEUTICS : INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENT..
05.08.Addex Therapeutics Ltd Reports Earnings Results for the Second Quarter Ended June 30, 2..
05.08.ADDEX THERAPEUTICS : Half Year Report
05.08.ADDEX THERAPEUTICS : to Present at the Baader Helvea Swiss Equities Conference
05.08.ADDEX THERAPEUTICS : to Ring the Nasdaq Stock Market Closing Bell
05.08.Addex voit ses coûts de recherche progresser sur les six premiers mois
05.08.PRESS RELEASE : Addex Reports 2021 Half Year and -2-
05.08.Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporat..
05.08.PRESS RELEASE : Addex Reports 2021 Half Year and Second Quarter Financial Results and Prov..
02.08.ADDEX THERAPEUTICS : Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head o..
02.08.ADDEX THERAPEUTICS : to Release Half-Year 2021 Financial Results and Host Conference Call ..
02.08.PRESS RELEASE : Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head ..
02.08.Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translatio..
02.08.PRESS RELEASE : Addex Therapeutics to Release Half-Year 2021 Financial Results and Host Co..
02.08.Addex Therapeutics Ltd Appoints Mikhail Kalinichev as Head of Translational Science
29.07.Bourse Zurich: les indices terminent de peu dans le vert
29.07.ADDEX THERAPEUTICS : and Indivior Extend Research Collaboration on GABAB Positive Alloster..
29.07.Bourse Zurich: le SMI passe au vert à l'approche de la mi-journée
29.07.Bourse Zurich: dans le rouge après les annonces de la Fed
29.07.Addex étend sa collaboration avec Indivior, perçoit 4 millions
29.07.PRESS RELEASE : Addex and Indivior Extend Research Collaboration on GABAB Positive Alloste..
29.07.ADDEX THERAPEUTICS : and Indivior Extend Research Collaboration on GABAB Positive Alloster..
29.07.Addex Therapeutics and Indivior Extend Research Collaboration on Gabab Positive Alloste..
29.07.Addex Therapeutics Ltd announced that it expects to receive $4 million in funding from ..
23.07.ADDEX THERAPEUTICS : to Present at Access to Giving Virtual Conference on July 14, 2021
23.07.ADDEX THERAPEUTICS : to Present at the 20th Annual Needham Virtual Healthcare Conference
23.07.ADDEX THERAPEUTICS : to Present at the H.C. Wainwright Global Life Sciences Conference
07.07.PRESS RELEASE : Addex Therapeutics to Present at Access to Giving Virtual Conference on Ju..
07.07.Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021
07.07.Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021
01.07.ADDEX THERAPEUTICS : Stanford University and University of Copenhagen Publish mGlu2 Struct..
01.07.ADDEX THERAPEUTICS : Stanford University and University of Copenhagen Publish mGlu2 Struct..
01.07.PRESS RELEASE : Addex, Stanford University and University of Copenhagen Publish mGlu2 Stru..
30.06.ADDEX THERAPEUTICS : INCORPORATION BY REFERENCE (Form 6-K)
30.06.ADDEX THERAPEUTICS : Enters Into At-The-Market ADS Offering Program With Cantor Fitzgerald
30.06.ADDEX THERAPEUTICS : to Offer American Depositary Shares via At-The-Market Program
30.06.ADDEX : nouveau programme de distribution d'ADS sur le Nasdaq
30.06.PRESS RELEASE : Addex Establishes At-The-Market ADS Equity Sale Program
30.06.Addex Establishes At-The-Market ADS Equity Sale Program
29.06.ADDEX THERAPEUTICS : Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia A..
29.06.ADDEX THERAPEUTICS : Starts Phase 2b/3 Trial of Dipraglurant in Dyskinesia Associated With..
29.06.ADDEX THERAPEUTICS : Initiates Clinical Trial For Dipraglurant In Parkinson's Patients
29.06.ADDEX THERAPEUTICS : Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia A..
29.06.Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia ..
29.06.PRESS RELEASE : Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant fo..
29.06.Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia ..
29.06.Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia ..
28.06.Addex débute une étude pivot 2b/3 sur le dipraglurant
17.06.ADDEX THERAPEUTICS : Shareholders Approve All Resolutions at Annual General Meeting (Form ..
17.06.ADDEX : l'assemblée générale valide en vrac les propositions du conseil
17.06.PRESS RELEASE : Addex Shareholders Approve All Resolutions at Annual General Meeting
17.06.Addex Shareholders Approve All Resolutions at Annual General Meeting
07.06.ADDEX THERAPEUTICS : Commences Enrollment in Phase 2 Trial of Epilepsy Drug
07.06.ADDEX THERAPEUTICS : First patients enrolled into multi-center U.S. study (Form 6-K)
07.06.ADDEX THERAPEUTICS : Enrolls First Patient in Mid-Stage Study of Epilepsy Drug
07.06.Addex et Janssen entament une phase II contre l'épilépsie
07.06.PRESS RELEASE : Addex Starts Phase 2 Clinical Study of ADX71149 for Epilepsy
07.06.Addex Starts Phase 2 Clinical Study of ADX71149 for Epilepsy
07.06.Addex Therapeutics Starts Phase 2 Clinical Study of ADX71149 for Epilepsy
24.05.PRESS RELEASE : Addex to Participate at the Benchmark Company Healthcare House Call Confer..
24.05.ADDEX THERAPEUTICS : to Participate at the Benchmark Company Healthcare House Call Confere..
24.05.Addex to Participate at the Benchmark Company Healthcare House Call Conference
17.05.Addex's Dipraglurant Restores Synaptic Plasticity in Models of Dystonia
17.05.PRESS RELEASE : Addex's Dipraglurant Restores Synaptic Plasticity in Models of Dystonia
17.05.Addex's Dipraglurant Restores Synaptic Plasticity in Models of Dystonia
1  2  3  4  5  6  7Weiter
Anstehende Termine für ADDEX THERAPEUTICS LTD